These results help to characterize differential involvement of the nucleus basalis of Meynert among neuropathologic Alzheimer disease subtypes, which may contribute to the differential benefit of acetylcholinesterase inhibitor treatment, especially in patients with young-onset Alzheimer disease. Here, ACHE is linked to Alzheimer disease.